Drug intelligence / Profile preview

Carpe

Development stage
Unknown
Lead developer
Carpe
Modality
Small Molecules
Administration
Topical
01

Overview

Carpe is a line of over-the-counter (OTC) topical antiperspirant products specifically formulated for the management of hyperhidrosis (excessive sweating) in various body regions, including the hands, feet, and underarms. Developed by the company Carpe, these formulations primarily utilize aluminum sesquichlorohydrate as the active pharmacological agent. The mechanism of action involves the formation of temporary physical plugs within the eccrine sweat gland ducts; when the aluminum salts are applied, they dissolve in the sweat and then precipitate, creating a barrier that prevents sweat from reaching the skin surface. Carpe is frequently recommended as a non-invasive, first-line management strategy for patients with primary focal hyperhidrosis who require more efficacy than standard commercial antiperspirants but wish to avoid the irritation often associated with high-concentration aluminum chloride prescription treatments.

Brand names
Carpe
Other names
Aluminum Sesquichlorohydrate

Beyond the preview

Go deeper on Carpe.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carpe.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call